E C Hanlon1, E Tasali, R Leproult, K L Stuhr, E Doncheck, H de Wit, C J Hillard, E Van Cauter. 1. Sleep, Metabolism, and Health Center (E.C.H., E.T., E.V.C.), Department of Medicine, and Department of Psychiatry and Behavioral Neuroscience (H.d.W.), University of Chicago, Chicago, Illinois 60637; Neuropsychology and Functional Neuroimaging Research Group (R.L.), Center for Research in Cognition and Neurosciences and the Université Libre de Bruxelles Neuroscience Institute, Université Libre de Bruxelles, B-1050 Bruxelles, Brussels, Belgium; and Neuroscience Research Center (K.L.S., E.D., C.J.H.), Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226.
Abstract
CONTEXT: The endocannabinoid (eCB) system is involved in the regulation of food intake and of peripheral metabolism. Although the cross talk between energy metabolism and the circadian system is well documented, little is known about a potential circadian modulation of human eCB activity. OBJECTIVE: The objective of the study was to define the 24-hour profile of circulating levels of the most abundant endogenous ligand of the CB1 receptor, 2-arachidonoylglycerol (2-AG), in healthy young nonobese adults studied under controlled bedtime, dietary, and activity conditions. METHODS: Fourteen subjects participated in this 4-day laboratory study with fixed light-dark cycles, standardized meals, and bedtimes. Sleep was recorded each night. On the third day, blood sampling at 15- to 30-minute intervals began at 9:30 pm and continued for 24 hours. Cortisol, leptin, and ghrelin were assayed on all samples, whereas the levels of 2-AG and its structural analog, 2-oleoylglycerol (2-OG), were measured at 60-minute intervals. RESULTS: All participants exhibited a large circadian variation of 2-AG serum concentrations with a nadir around midsleep, coincident with the middle of the overnight fast. Levels of 2-AG increased continually across the morning, peaking in the early to midafternoon. Peak values represented, on average, a nearly 3-fold increase above nocturnal nadir levels. Concentrations of 2-OG followed a similar pattern, although with a shorter morning increase and lower amplitude. CONCLUSIONS: The findings demonstrate that activity of the eCB system is profoundly modulated by circadian rhythmicity and suggest that its impact on the regulation of food intake is suppressed during sleep and is maximal during early to midafternoon.
CONTEXT: The endocannabinoid (eCB) system is involved in the regulation of food intake and of peripheral metabolism. Although the cross talk between energy metabolism and the circadian system is well documented, little is known about a potential circadian modulation of human eCB activity. OBJECTIVE: The objective of the study was to define the 24-hour profile of circulating levels of the most abundant endogenous ligand of the CB1 receptor, 2-arachidonoylglycerol (2-AG), in healthy young nonobese adults studied under controlled bedtime, dietary, and activity conditions. METHODS: Fourteen subjects participated in this 4-day laboratory study with fixed light-dark cycles, standardized meals, and bedtimes. Sleep was recorded each night. On the third day, blood sampling at 15- to 30-minute intervals began at 9:30 pm and continued for 24 hours. Cortisol, leptin, and ghrelin were assayed on all samples, whereas the levels of 2-AG and its structural analog, 2-oleoylglycerol (2-OG), were measured at 60-minute intervals. RESULTS: All participants exhibited a large circadian variation of 2-AG serum concentrations with a nadir around midsleep, coincident with the middle of the overnight fast. Levels of 2-AG increased continually across the morning, peaking in the early to midafternoon. Peak values represented, on average, a nearly 3-fold increase above nocturnal nadir levels. Concentrations of 2-OG followed a similar pattern, although with a shorter morning increase and lower amplitude. CONCLUSIONS: The findings demonstrate that activity of the eCB system is profoundly modulated by circadian rhythmicity and suggest that its impact on the regulation of food intake is suppressed during sleep and is maximal during early to midafternoon.
Authors: J M Mullington; J L Chan; H P A Van Dongen; M P Szuba; J Samaras; N J Price; H K Meier-Ewert; D F Dinges; C S Mantzoros Journal: J Neuroendocrinol Date: 2003-09 Impact factor: 3.627
Authors: Giancarlo Colombo; Salvatore Serra; Giovanni Vacca; Mauro A M Carai; Gian Luigi Gessa Journal: Pharmacol Biochem Behav Date: 2005-06 Impact factor: 3.533
Authors: Pavel E Rueda-Orozco; Edgar Soria-Gomez; Corinne J Montes-Rodriguez; Marina Martínez-Vargas; Oscar Galicia; Luz Navarro; Oscar Prospero-García Journal: Psychopharmacology (Berl) Date: 2007-09-06 Impact factor: 4.530
Authors: Deanna M Arble; Joseph Bass; Aaron D Laposky; Martha H Vitaterna; Fred W Turek Journal: Obesity (Silver Spring) Date: 2009-09-03 Impact factor: 5.002
Authors: Erin C Hanlon; Esra Tasali; Rachel Leproult; Kara L Stuhr; Elizabeth Doncheck; Harriet de Wit; Cecilia J Hillard; Eve Van Cauter Journal: Sleep Date: 2016-03-01 Impact factor: 5.849
Authors: Erin C Hanlon; Rachel Leproult; Kara L Stuhr; Elizabeth M Doncheck; Cecilia J Hillard; Eve Van Cauter Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958
Authors: Sang-Hun Lee; Marco Ledri; Blanka Tóth; Ivan Marchionni; Christopher M Henstridge; Barna Dudok; Kata Kenesei; László Barna; Szilárd I Szabó; Tibor Renkecz; Michelle Oberoi; Masahiko Watanabe; Charles L Limoli; George Horvai; Ivan Soltesz; István Katona Journal: J Neurosci Date: 2015-07-08 Impact factor: 6.167